Keryx Biopharmaceuticals, Inc.
(NASDAQ : KERX)

( )
KERX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading KERX News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.66%68.831.0%$926.55m
AMGNAmgen Inc.
-0.31%172.610.8%$655.47m
BIIBBiogen Inc.
0.25%287.630.9%$526.94m
CELGCelgene Corporation
-0.14%119.271.0%$480.99m
REGNRegeneron Pharmaceuticals, Inc.
-0.37%370.221.9%$341.26m
ALXNAlexion Pharmaceuticals, Inc.
0.72%130.832.0%$299.85m
TSROTESARO, Inc.
-0.17%189.9415.3%$195.91m
INCYIncyte Corporation
-0.82%121.362.3%$163.54m
ILMNIllumina, Inc.
0.09%162.303.9%$144.45m
VRTXVertex Pharmaceuticals Incorporated
-0.88%85.792.6%$139.38m
EXELExelixis, Inc.
-2.12%22.625.5%$127.92m
CLVSClovis Oncology, Inc.
-2.86%61.1916.4%$127.65m
AAgilent Technologies, Inc.
-0.04%51.331.7%$116.31m
ACADACADIA Pharmaceuticals Inc.
-0.15%39.1419.0%$93.49m
BMRNBioMarin Pharmaceutical Inc.
-0.50%89.794.0%$90.43m

Company Profile

Keryx Biopharmaceuticals, Inc. engages in the development and commercialization of medicines for the treatment of renal disease. Its products include phosphate-binding medicines, intravenous iron, and other medications. The company was founded in October 1998 and is headquartered in Boston, MA.